State Cancer Profiles

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Prostate (Late Stage^), 2018-2022

All Races (includes Hispanic), Male, All Ages

Sorted by Rate

Explanation of Column Headers
Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.

Other Notes

• Larger confidence intervals indicate less stability of the data. This is often due to low counts that are not quite low enough to be suppressed.
• Data is currently being suppressed if there are fewer than 16 counts for the time period.

Line by Line Interpretation of the Report

US (SEER+NPCR)¹

• Rate : The incidence rate is 26.0 with a 95% confidence interval from 25.9 to 26.1 and 52,748 average annual cases over 2018-2022.
• CI*Rank ⋔ : N/A

Puerto Rico²

• Rate : The incidence rate is 16.0 with a 95% confidence interval from 15.3 to 16.8 and 369 average annual cases over 2018-2022.
• CI*Rank ⋔ : N/A
• Percent of Cases with Late Stage :

Alabama²

• Rate : The incidence rate is 18.8 with a 95% confidence interval from 18.1 to 19.5 and 604 average annual cases over 2018-2022.
• CI*Rank ⋔ : 51 (48, 51)
• Percent of Cases with Late Stage :

Nevada²

• Rate : The incidence rate is 19.1 with a 95% confidence interval from 18.3 to 20.1 and 372 average annual cases over 2018-2022.
• CI*Rank ⋔ : 50 (47, 51)
• Percent of Cases with Late Stage :

Arizona²

• Rate : The incidence rate is 19.3 with a 95% confidence interval from 18.7 to 19.9 and 912 average annual cases over 2018-2022.
• CI*Rank ⋔ : 49 (47, 51)
• Percent of Cases with Late Stage :

New Mexico⁷

• Rate : The incidence rate is 20.2 with a 95% confidence interval from 19.1 to 21.3 and 288 average annual cases over 2018-2022.
• CI*Rank ⋔ : 48 (45, 51)
• Percent of Cases with Late Stage :

Wyoming²

• Rate : The incidence rate is 21.6 with a 95% confidence interval from 19.5 to 23.9 and 86 average annual cases over 2018-2022.
• CI*Rank ⋔ : 47 (35, 51)
• Percent of Cases with Late Stage :

Arkansas²

• Rate : The incidence rate is 21.8 with a 95% confidence interval from 20.8 to 22.8 and 411 average annual cases over 2018-2022.
• CI*Rank ⋔ : 46 (42, 48)
• Percent of Cases with Late Stage :

West Virginia²

• Rate : The incidence rate is 22.0 with a 95% confidence interval from 20.8 to 23.2 and 282 average annual cases over 2018-2022.
• CI*Rank ⋔ : 45 (39, 48)
• Percent of Cases with Late Stage :

Oklahoma²

• Rate : The incidence rate is 22.0 with a 95% confidence interval from 21.1 to 22.9 and 519 average annual cases over 2018-2022.
• CI*Rank ⋔ : 44 (41, 48)
• Percent of Cases with Late Stage :

Florida²

• Rate : The incidence rate is 22.5 with a 95% confidence interval from 22.2 to 22.9 and 3,559 average annual cases over 2018-2022.
• CI*Rank ⋔ : 43 (41, 46)
• Percent of Cases with Late Stage :

Kansas²

• Rate : The incidence rate is 23.8 with a 95% confidence interval from 22.7 to 24.8 and 426 average annual cases over 2018-2022.
• CI*Rank ⋔ : 42 (33, 45)
• Percent of Cases with Late Stage :

Alaska²

• Rate : The incidence rate is 23.8 with a 95% confidence interval from 21.5 to 26.3 and 92 average annual cases over 2018-2022.
• CI*Rank ⋔ : 41 (21, 48)
• Percent of Cases with Late Stage :

Texas⁷

• Rate : The incidence rate is 23.8 with a 95% confidence interval from 23.5 to 24.2 and 3,527 average annual cases over 2018-2022.
• CI*Rank ⋔ : 40 (35, 43)
• Percent of Cases with Late Stage :

Tennessee²

• Rate : The incidence rate is 23.9 with a 95% confidence interval from 23.2 to 24.6 and 1,034 average annual cases over 2018-2022.
• CI*Rank ⋔ : 39 (34, 43)
• Percent of Cases with Late Stage :

Kentucky⁷

• Rate : The incidence rate is 24.0 with a 95% confidence interval from 23.2 to 24.9 and 658 average annual cases over 2018-2022.
• CI*Rank ⋔ : 38 (33, 43)
• Percent of Cases with Late Stage :

Virginia²

• Rate : The incidence rate is 24.1 with a 95% confidence interval from 23.4 to 24.7 and 1,231 average annual cases over 2018-2022.
• CI*Rank ⋔ : 37 (34, 43)
• Percent of Cases with Late Stage :

South Carolina²

• Rate : The incidence rate is 24.2 with a 95% confidence interval from 23.4 to 25.0 and 815 average annual cases over 2018-2022.
• CI*Rank ⋔ : 36 (33, 42)
• Percent of Cases with Late Stage :

Delaware²

• Rate : The incidence rate is 24.4 with a 95% confidence interval from 22.8 to 26.2 and 169 average annual cases over 2018-2022.
• CI*Rank ⋔ : 35 (23, 46)
• Percent of Cases with Late Stage :

New Jersey⁷

• Rate : The incidence rate is 25.1 with a 95% confidence interval from 24.5 to 25.7 and 1,435 average annual cases over 2018-2022.
• CI*Rank ⋔ : 34 (30, 38)
• Percent of Cases with Late Stage :

Missouri²

• Rate : The incidence rate is 25.6 with a 95% confidence interval from 24.9 to 26.4 and 1,016 average annual cases over 2018-2022.
• CI*Rank ⋔ : 33 (24, 36)
• Percent of Cases with Late Stage :

Maryland²

• Rate : The incidence rate is 25.8 with a 95% confidence interval from 25.0 to 26.6 and 946 average annual cases over 2018-2022.
• CI*Rank ⋔ : 32 (23, 36)
• Percent of Cases with Late Stage :

Rhode Island²

• Rate : The incidence rate is 26.0 with a 95% confidence interval from 24.3 to 27.8 and 187 average annual cases over 2018-2022.
• CI*Rank ⋔ : 31 (15, 41)
• Percent of Cases with Late Stage :

Utah⁷

• Rate : The incidence rate is 26.1 with a 95% confidence interval from 24.9 to 27.3 and 380 average annual cases over 2018-2022.
• CI*Rank ⋔ : 30 (18, 37)
• Percent of Cases with Late Stage :

Michigan²

• Rate : The incidence rate is 26.1 with a 95% confidence interval from 25.6 to 26.7 and 1,753 average annual cases over 2018-2022.
• CI*Rank ⋔ : 29 (22, 34)
• Percent of Cases with Late Stage :

Indiana²

• Rate : The incidence rate is 26.3 with a 95% confidence interval from 25.6 to 27.0 and 1,076 average annual cases over 2018-2022.
• CI*Rank ⋔ : 28 (21, 34)
• Percent of Cases with Late Stage :

Georgia⁷

• Rate : The incidence rate is 26.3 with a 95% confidence interval from 25.7 to 27.0 and 1,543 average annual cases over 2018-2022.
• CI*Rank ⋔ : 26 (21, 33)
• Percent of Cases with Late Stage :

Pennsylvania²

• Rate : The incidence rate is 26.4 with a 95% confidence interval from 25.9 to 26.9 and 2,330 average annual cases over 2018-2022.
• CI*Rank ⋔ : 27 (21, 33)
• Percent of Cases with Late Stage :

California⁷

• Rate : The incidence rate is 26.5 with a 95% confidence interval from 26.2 to 26.8 and 5,853 average annual cases over 2018-2022.
• CI*Rank ⋔ : 25 (21, 31)
• Percent of Cases with Late Stage :

North Carolina²

• Rate : The incidence rate is 26.8 with a 95% confidence interval from 26.3 to 27.4 and 1,690 average annual cases over 2018-2022.
• CI*Rank ⋔ : 24 (19, 31)
• Percent of Cases with Late Stage :

Ohio²

• Rate : The incidence rate is 26.9 with a 95% confidence interval from 26.3 to 27.4 and 2,052 average annual cases over 2018-2022.
• CI*Rank ⋔ : 23 (19, 31)
• Percent of Cases with Late Stage :

Maine²

• Rate : The incidence rate is 27.4 with a 95% confidence interval from 25.9 to 28.9 and 289 average annual cases over 2018-2022.
• CI*Rank ⋔ : 22 (11, 34)
• Percent of Cases with Late Stage :

Mississippi²

• Rate : The incidence rate is 27.5 with a 95% confidence interval from 26.4 to 28.6 and 494 average annual cases over 2018-2022.
• CI*Rank ⋔ : 21 (12, 31)
• Percent of Cases with Late Stage :

Colorado²

• Rate : The incidence rate is 27.6 with a 95% confidence interval from 26.7 to 28.4 and 888 average annual cases over 2018-2022.
• CI*Rank ⋔ : 20 (14, 28)
• Percent of Cases with Late Stage :

Hawaii⁷

• Rate : The incidence rate is 27.8 with a 95% confidence interval from 26.4 to 29.3 and 282 average annual cases over 2018-2022.
• CI*Rank ⋔ : 19 (9, 32)
• Percent of Cases with Late Stage :

Oregon²

• Rate : The incidence rate is 27.9 with a 95% confidence interval from 27.0 to 28.8 and 783 average annual cases over 2018-2022.
• CI*Rank ⋔ : 18 (13, 26)
• Percent of Cases with Late Stage :

New York⁷

• Rate : The incidence rate is 28.1 with a 95% confidence interval from 27.7 to 28.6 and 3,478 average annual cases over 2018-2022.
• CI*Rank ⋔ : 17 (14, 22)
• Percent of Cases with Late Stage :

Massachusetts²

• Rate : The incidence rate is 28.7 with a 95% confidence interval from 27.9 to 29.4 and 1,268 average annual cases over 2018-2022.
• CI*Rank ⋔ : 16 (10, 21)
• Percent of Cases with Late Stage :

Nebraska²

• Rate : The incidence rate is 28.8 with a 95% confidence interval from 27.4 to 30.2 and 351 average annual cases over 2018-2022.
• CI*Rank ⋔ : 15 (6, 24)
• Percent of Cases with Late Stage :

Idaho⁷

• Rate : The incidence rate is 28.9 with a 95% confidence interval from 27.4 to 30.4 and 326 average annual cases over 2018-2022.
• CI*Rank ⋔ : 14 (6, 25)
• Percent of Cases with Late Stage :

Illinois⁷

• Rate : The incidence rate is 29.5 with a 95% confidence interval from 28.9 to 30.0 and 2,275 average annual cases over 2018-2022.
• CI*Rank ⋔ : 13 (7, 16)
• Percent of Cases with Late Stage :

Washington¹

• Rate : The incidence rate is 29.6 with a 95% confidence interval from 28.9 to 30.3 and 1,345 average annual cases over 2018-2022.
• CI*Rank ⋔ : 12 (6, 16)
• Percent of Cases with Late Stage :

Connecticut⁷

• Rate : The incidence rate is 29.8 with a 95% confidence interval from 28.8 to 30.9 and 704 average annual cases over 2018-2022.
• CI*Rank ⋔ : 11 (5, 17)
• Percent of Cases with Late Stage :

New Hampshire²

• Rate : The incidence rate is 29.9 with a 95% confidence interval from 28.4 to 31.6 and 297 average annual cases over 2018-2022.
• CI*Rank ⋔ : 10 (4, 21)
• Percent of Cases with Late Stage :

Montana²

• Rate : The incidence rate is 30.0 with a 95% confidence interval from 28.3 to 31.8 and 240 average annual cases over 2018-2022.
• CI*Rank ⋔ : 9 (4, 21)
• Percent of Cases with Late Stage :

Iowa⁷

• Rate : The incidence rate is 30.5 with a 95% confidence interval from 29.4 to 31.6 and 632 average annual cases over 2018-2022.
• CI*Rank ⋔ : 8 (4, 15)
• Percent of Cases with Late Stage :

Louisiana⁷

• Rate : The incidence rate is 30.5 with a 95% confidence interval from 29.6 to 31.5 and 862 average annual cases over 2018-2022.
• CI*Rank ⋔ : 7 (4, 14)
• Percent of Cases with Late Stage :

South Dakota²

• Rate : The incidence rate is 30.6 with a 95% confidence interval from 28.5 to 32.8 and 173 average annual cases over 2018-2022.
• CI*Rank ⋔ : 6 (3, 21)
• Percent of Cases with Late Stage :

North Dakota²

• Rate : The incidence rate is 31.7 with a 95% confidence interval from 29.4 to 34.2 and 147 average annual cases over 2018-2022.
• CI*Rank ⋔ : 5 (1, 17)
• Percent of Cases with Late Stage :

Wisconsin²

• Rate : The incidence rate is 32.5 with a 95% confidence interval from 31.7 to 33.3 and 1,271 average annual cases over 2018-2022.
• CI*Rank ⋔ : 4 (2, 6)
• Percent of Cases with Late Stage :

Minnesota²

• Rate : The incidence rate is 34.2 with a 95% confidence interval from 33.3 to 35.1 and 1,223 average annual cases over 2018-2022.
• CI*Rank ⋔ : 3 (1, 4)
• Percent of Cases with Late Stage :

District of Columbia²

• Rate : The incidence rate is 34.2 with a 95% confidence interval from 31.3 to 37.4 and 104 average annual cases over 2018-2022.
• CI*Rank ⋔ : 2 (1, 11)
• Percent of Cases with Late Stage :

Vermont²

• Rate : The incidence rate is 35.0 with a 95% confidence interval from 32.5 to 37.6 and 166 average annual cases over 2018-2022.
• CI*Rank ⋔ : 1 (1, 6)
• Percent of Cases with Late Stage :

Notes:
Created by statecancerprofiles.cancer.gov on 03/24/2026 2:00 pm.

State Cancer Registries may provide more current or more local data.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (SEER areas use 20 age groups and NPCR areas use 19 age groups). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage with Expanded Regional Codes (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.

Source: SEER and NPCR data. For more specific information please see the table.

Data for United States does not include Puerto Rico.